Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of CNS Relapse Treated in the Rituximab Era

Blood (2019) 134 (Supplement_1): 1619.

https://doi.org/10.1182/blood-2019-131435

Published: 2019

Journal Articles

R-m-NHL-BFM-90/R-EPOCH Protocol in the Treatment of Patients with Primary Mediastinal Lymphoma: First Results

Nelly G Gabeeva, PhD, Darya A Koroleva, Svetlana A Tatarnikova, Anna K Smolyaninova, Svetlana Smirnova, MD PhD, Elena E Nikulina, Alla M. Kovrigina, MD PhD, Andrey B Sudarikov, PhD DSc, Eugene E. Zvonkov, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5334.

https://doi.org/10.1182/blood-2019-127944

Published: 2019

Journal Articles

Liquid Biopsy Is Useful to Identify the Genetic Profile of NHL-B at Diagnosis in Different Histological Subtypes

Mariana Bastos-Oreiro, MD PhD, Julia Suárez González, Natalia Carolina Carrión, Cristina Andres, Solsireey Moreno, Diego Carbonell, Mr, María Chicano Lavilla, PhD, Gillen Oarbeascoa, MD, Francisco Diaz Crespo, Javier Menarguez, MD PhD, José Luis Díez-Martín, MD PhD, Ismael Buño, PhD, Carolina Martínez-Laperche

Blood (2019) 134 (Supplement_1): 5216.

https://doi.org/10.1182/blood-2019-129868

Published: 2019

Journal Articles

The Real Life Accessibility to CAR T-Cell Therapy: Current Experience in the Only Active Center in Italy

Anna Guidetti, MD, Giulia Perrone, MD, Paola Coluccia, MD, Luca Fumagalli, MD, Anna Dodero, MD, Lucia Farina, MD, Flavio Arienti, MD, Filippo Bagnoli, MD, Luca Pappalettera, MD, Debora Degli Innocenti, Cristiana Carniti, PhD, Daniela Codazzi, MD, Paolo Corradini

Blood (2019) 134 (Supplement_1): 5619.

https://doi.org/10.1182/blood-2019-125286

Published: 2019

Journal Articles

CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas

Mazyar Shadman, MD, Ajay K. Gopal, MD, Stephen D. Smith, MD, Ryan C. Lynch, MD, Chaitra S. Ujjani, MD, Cameron J. Turtle, MBBS, PhD, Adam Greenbaum, MD PhD, Mary Redman, Cecilia Yeung, MD, Martina Sersch, MD PhD, Edus H. Warren, MD PhD, David G. Maloney, MD PhD, Brian G. Till, MD

Blood (2019) 134 (Supplement_1): 3235.

https://doi.org/10.1182/blood-2019-125102

Published: 2019

Journal Articles

Dabaja BS, Hoppe BS, Plastaras JP, et al. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood. 2018;132(16):1635-1646.

Blood (2019) 133 (12): 1384–1385.

https://doi.org/10.1182/blood-2019-02-900738

Published: 2019

Journal Articles

The First Experience of Treatment of Patients with Primary Mediastinal Lymphoma Using the R-m-NHL-BFM-90/R-EPOCH Protocol

Nelly Gabeeva, PhD, Daria Koroleva, Anastasya Belyaeva, Anna Smolyaninova, Natalia G. Chernova, MD PhD, Valery Lapin, Alla M. Kovrigina, MD PhD, Eugene E. Zvonkov, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5391.

https://doi.org/10.1182/blood-2018-99-115080

Published: 2018

Journal Articles

Frequency of MYC Overexpression and MYC-BCL2 Double Expression (DEL) in Localized Diffuse Large B-Cell Lymphoma (DLBCL) at a Large Academic Cancer Center

Stephanie Ryanne Corder, BS, Ankit Agarwal, MD MBA, Jonathan Galeotti, MD MS, Xianming Tan, PhD, Natalie S Grover, MD, Christopher Dittus, DO

Blood (2018) 132 (Supplement 1): 4223.

https://doi.org/10.1182/blood-2018-99-111902

Published: 2018

Journal Articles

Ibrutinib, Bendamustine, Rituximab Combination for Relapsed and Refractory Aggressive B Cell Lymphoma — Interim Analysis of Phase II Clinical Trial

Meirav Kedmi, MD, Elena Ribakovsy, MD, Ohad Benjamini, MD, Ginette Schiby, MD, Iris Barshack, MD, Stephen P Raskin, MD, Yael Eshet, MD, Ramit Mehr, PhD, Guy Bitansky, Arnon Nagler, MD, Abraham Avigdor, MD

Blood (2018) 132 (Supplement 1): 4186.

https://doi.org/10.1182/blood-2018-99-111658

Published: 2018

Journal Articles

Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines

Bouthaina Shbib Dabaja, Bradford S. Hoppe, John P. Plastaras, Wayne Newhauser, Katerina Rosolova, Stella Flampouri, Radhe Mohan, N. George Mikhaeel, Youlia Kirova, Lena Specht, Joachim Yahalom

Blood (2018) 132 (16): 1635–1646.

https://doi.org/10.1182/blood-2018-03-837633

Published: 2018

Includes: Supplemental data

Journal Articles

Salvage High-Dose Melphalane and Autologous Peripheral Blood Stem Cell Transplantation for Diffuse Large b-Cell Lymphoma Refractory to 2nd or 3rd Line Treatment

Dominic Kaddu-Mulindwa, Gerhard Held, MD, Michael Pfreundschuh, MD, PhD, Joerg Thomas Bittenbring, MD

Blood (2016) 128 (22): 5881.

https://doi.org/10.1182/blood.V128.22.5881.5881

Published: 2016

Journal Articles

Pre-Clinical Investigation of Targeted Therapies for Double Hit Diffuse Large B-Cell Lymphoma (DH-DLBCL)

Priyank P. Patel, MD, Alison Zeccola, Vishala T. Neppalli, MD, Juan J Gu, PhD, Cory Mavis, MSc, Sheila Sait, PhD, Francisco J. Hernandez-Ilizaliturri, MD

Blood (2015) 126 (23): 5122.

https://doi.org/10.1182/blood.V126.23.5122.5122

Published: 2015

Journal Articles

Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

Kieron Dunleavy, Wyndham H. Wilson

Blood (2015) 125 (1): 33–39.

https://doi.org/10.1182/blood-2014-05-575092

Published: 2015

Journal Articles

High Rate of Initial Treatment Failure in Patients with Primary Mediastinal B-Cell Lymphoma Treated with R-CHOP

Jeremy S. Abramson, MD, Matthew D Hellmann, MD, Yang Feng, PhD, Jeffrey A. Barnes, MD, PhD, Tak Takvorian, MD, Christiana E. Toomey, Michael Sheppard, James S. Michaelson, PhD, Donna Neuberg, ScD, Ephraim P. Hochberg, MD

Blood (2011) 118 (21): 1601.

https://doi.org/10.1182/blood.V118.21.1601.1601

Published: 2011

Journal Articles

Myc -Mediated Lymphomagenesis Is Driven by DNA Methylation Changes Induced by DNMT3B7 Expression and Dnmt3b Heterozygosity

Aparna Vasanthakumar, PhD, Janet B Lepore, MS, Matthew H Zegarek, BS, Masha Kocherginsky, PhD, Mahi Singh, Lucy A Godley, MD, PhD

Blood (2011) 118 (21): 225.

https://doi.org/10.1182/blood.V118.21.225.225

Published: 2011

Journal Articles

Myeloablative Haploidentical Bone Marrow Transplantation with T Cell Replete Grafts and Post-Transplant Cyclophosphamide: Results of a Phase II Clinical Trial,

Heather J. Symons, Allen R. Chen, MD, PhD, MHS, Leo Luznik, Yvette L. Kasamon, Javier Bolanos Meade, MD, Richard J. Jones, Ephraim J. Fuchs

Blood (2011) 118 (21): 4151.

https://doi.org/10.1182/blood.V118.21.4151.4151

Published: 2011

Journal Articles

Excellent Results In the Treatment of Primary Mediastinal Lymphomas

Tamas Schneider, Zsuzsanna Molnar, Erika Toth, Jozsef Lovey, Erika Szaleczky, Erika Varady, Beata Deak, Fatima Varga, Sandor Fekete, MD, Andras Rosta

Blood (2010) 116 (21): 4915.

https://doi.org/10.1182/blood.V116.21.4915.4915

Published: 2010

Journal Articles

HLA-Haploidentical Bone Marrow Transplantation (BMT) for High Risk Hematologic Malignancies Using Myeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

Heather Symons, MD, MHS, Allen R. Chen, MD, PhD, MHS, M. Sue Leffell, PhD, Marianna Zahurak, M.S., Kathy Schultz, Heather Karaszkiewicz, Leo Luznik, MD, Javier Bolanos Meade, MD, Yvette L. Kasamon, MD, Lode J. Swinnen, MD, Douglas Edward Gladstone, MD, Richard J. Jones, MD, Ephraim Fuchs, MD, MBA

Blood (2010) 116 (21): 2362.

https://doi.org/10.1182/blood.V116.21.2362.2362

Published: 2010

Journal Articles

Interim-Positron Emission Tomography with [18F]Fluorodeoxyglucose (interim-PET) Evaluation In Mediastinal Lymphoma Including Hodgkin Lymphoma (HL) and Primary Mediastinal Large B-Cell Lymphoma (PMBL)

Caroline Algrin, Nathalie Bérenger, Sylvie Chevret, Laetitia Vercellino, Cédric de Bazelaire, Pauline Brice, David Sibon, Patricia Franchi, Josette Briere, Eric de Kerviler, Christian Gisselbrecht, Catherine Thieblemont

Blood (2010) 116 (21): 2860.

https://doi.org/10.1182/blood.V116.21.2860.2860

Published: 2010

Journal Articles

Rituximab Maintenenance Therapy in CD20+ B-Cell Non-Hodgkin-Lymphoma – Final Results of a Multicenter Prospective Randomised Phase II Study.

Mathias Witzens-Harig, Axel Benner, Michael Rieger, Fabienne McClanahan, Manfred Hensel, Kai Neben, Peter Dreger, Eva Lengfelder, Ingo Schmidt-Wolf, Krämer Alwin, Anthony D. Ho

Blood (2009) 114 (22): 1707.

https://doi.org/10.1182/blood.V114.22.1707.1707

Published: 2009

NARROW

Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of CNS Relapse Treated in the Rituximab Era

R-m-NHL-BFM-90/R-EPOCH Protocol in the Treatment of Patients with Primary Mediastinal Lymphoma: First Results

Liquid Biopsy Is Useful to Identify the Genetic Profile of NHL-B at Diagnosis in Different Histological Subtypes

The Real Life Accessibility to CAR T-Cell Therapy: Current Experience in the Only Active Center in Italy

CD20 Targeted CAR-T for High-Risk B-Cell Non-Hodgkin Lymphomas

Dabaja BS, Hoppe BS, Plastaras JP, et al. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood. 2018;132(16):1635-1646.

The First Experience of Treatment of Patients with Primary Mediastinal Lymphoma Using the R-m-NHL-BFM-90/R-EPOCH Protocol

Frequency of MYC Overexpression and MYC-BCL2 Double Expression (DEL) in Localized Diffuse Large B-Cell Lymphoma (DLBCL) at a Large Academic Cancer Center

Ibrutinib, Bendamustine, Rituximab Combination for Relapsed and Refractory Aggressive B Cell Lymphoma — Interim Analysis of Phase II Clinical Trial

Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines

Salvage High-Dose Melphalane and Autologous Peripheral Blood Stem Cell Transplantation for Diffuse Large b-Cell Lymphoma Refractory to 2nd or 3rd Line Treatment

Pre-Clinical Investigation of Targeted Therapies for Double Hit Diffuse Large B-Cell Lymphoma (DH-DLBCL)

Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

High Rate of Initial Treatment Failure in Patients with Primary Mediastinal B-Cell Lymphoma Treated with R-CHOP

Myc -Mediated Lymphomagenesis Is Driven by DNA Methylation Changes Induced by DNMT3B7 Expression and Dnmt3b Heterozygosity

Myeloablative Haploidentical Bone Marrow Transplantation with T Cell Replete Grafts and Post-Transplant Cyclophosphamide: Results of a Phase II Clinical Trial,

Excellent Results In the Treatment of Primary Mediastinal Lymphomas

HLA-Haploidentical Bone Marrow Transplantation (BMT) for High Risk Hematologic Malignancies Using Myeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

Interim-Positron Emission Tomography with [18F]Fluorodeoxyglucose (interim-PET) Evaluation In Mediastinal Lymphoma Including Hodgkin Lymphoma (HL) and Primary Mediastinal Large B-Cell Lymphoma (PMBL)

Rituximab Maintenenance Therapy in CD20+ B-Cell Non-Hodgkin-Lymphoma – Final Results of a Multicenter Prospective Randomised Phase II Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only